ARTICLE | Company News
Oxurion, Beta Therapeutics partner to develop heparanase inhibitors
November 16, 2018 5:29 PM UTC
Oxurion N.V. (Euronext:OXUR) and Beta Therapeutics Pty. Ltd. (Canberra, Australia) partnered to develop heparanase inhibitors to treat retinal disorders, including dry age-related macular degeneration (AMD)...